TransEnterix (TRXC) Provides Preliminary 2020 Year-End Corporate Update

Go back to TransEnterix (TRXC) Provides Preliminary 2020 Year-End Corporate Update

TransEnterix (TRXC) Reports 25M Share Registered Direct Offering at $1.25/Sh

January 12, 2021 7:54 AM EST

TransEnterix, Inc. (NYSE: TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that it has entered into securities purchase agreements with several institutional investors for the purchase and sale, in a... More